OBI Pharma, Inc. (TPEX:4174)

OBI Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	16,304	15,388	15,910	15,831	22,680	26,213
Market Cap Growth	-3.28%	-3.28%	0.50%	-30.20%	-13.48%	5.56%
Enterprise Value	14,683	15,525	14,396	12,411	21,039	22,895
Last Close Price	62.00	58.50	68.99	68.69	112.19	136.79
PS Ratio	231.05	245.51	382.92	3360.52	1208.19	186.06
PB Ratio	4.00	3.19	3.21	2.58	5.86	5.42
P/TBV Ratio	4.10	4.10	4.26	3.73	9.79	6.94
EV/Sales Ratio	234.27	247.70	346.49	2634.54	1120.77	162.51
Debt / Equity Ratio	0.11	0.11	0.11	0.05	0.08	0.05
Asset Turnover	0.01	0.01	0.01	0.00	0.00	0.02
Inventory Turnover	5.18	5.18	4.80	2.85	5.24	1.12
Quick Ratio	7.65	7.65	17.73	21.71	8.18	15.05
Current Ratio	8.34	8.34	19.92	22.76	8.72	15.67
Return on Equity (ROE)	-51.01%	-51.01%	-22.83%	-37.96%	-39.45%	-27.69%
Return on Assets (ROA)	-26.33%	-26.33%	-21.35%	-23.86%	-21.83%	-15.49%
Return on Capital (ROIC)	-27.38%	-27.38%	-21.90%	-25.05%	-23.20%	-16.24%
Earnings Yield	-14.17%	-15.01%	-6.58%	-10.19%	-6.75%	-5.26%
FCF Yield	-11.94%	-12.65%	-11.03%	-11.84%	-5.76%	-6.84%
Buyback Yield / Dilution	-2.00%	-1.97%	-3.12%	-11.65%	-0.18%	-3.56%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.